ASSESSMENT OF NEW THERAPIES FOR THE PREVENTION OF NEUROSENSORY HEARING LOSS
Deafness is a major public health problem due to its high prevalence and impact on the quality of life of the population. At all stages of life, there are environmental factors that contribute to hearing loss, the most prominent being noise and ototoxic substances.
There is currently no restorative drug treatment for any form of deafness, with replacement therapies available only with devices (hearing aids and implants). Research into new preventive, restorative and regenerative therapies for hearing is essential.
The authors present preclinical research work to assess the therapeutic utility of antioxidant and anti-inflammatory substances in animal models of ototoxic drug-induced hearing loss and noise exposure. This is experimental work that may have a clinical application in the near future by highlighting the protective effect of these substances on hearing and the ears.
For your bibliography: Rivera et. al. (2017): “Assessment of new therapies for the prevention of neurosensory hearing loss”. FIAPAS Journal, January-March 2017, No. 160, FIAPAS Special.